CEA as a blood-based biomarker in anal cancer
CONCLUSIONS: Despite interesting patterns of abnormally high CEA in SCCA patients with advanced disease, and correlation of increased CEA with disease progression (and conversely decreased CEA with disease response), CEA is not associated with survival outcomes in SCCA, and is not a clinically relevant biomarker in this disease.PMID:34084278 | PMC:PMC8169063 | DOI:10.18632/oncotarget.27959
Source: Oncotarget - Category: Cancer & Oncology Authors: Robert Hester Shailesh Advani Asif Rashid Emma Holliday Craig Messick Prajnan Das Yi-Qian N You Cullen Taniguchi Eugene J Koay Brian Bednarski Miguel Rodriguez-Bigas John Skibber Robert Wolff George J Chang Bruce D Minsky Wai Chin Foo Nicole Rothschild Va Source Type: research
More News: Adenocarcinoma | Anal Cancer | Cancer | Cancer & Oncology | Carcinoma | Colorectal Cancer | Skin Cancer | Squamous Cell Carcinoma | Statistics | Texas University